title: Ontology-based knowledge management of troglitazone-induced hepatotoxicity.
authors.affiliation: TheraSTrat AG, Allschwill, Switzerland. hubert.hug@therstrat.com
authors.forename: Hubert
authors.initials: H
authors.lastname: Hug
authors.forename: Robert
authors.initials: R
authors.lastname: Dannecker
authors.forename: Richard
authors.initials: R
authors.lastname: Schindler
authors.forename: Dario
authors.initials: D
authors.lastname: Bagatto
authors.forename: André
authors.initials: A
authors.lastname: Stephan
authors.forename: Ralf Arno
authors.initials: RA
authors.lastname: Wess
authors.forename: Joseph
authors.initials: J
authors.lastname: Gut
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000235:genetics; D002839:Chromans / Q000009:adverse effects* / Q000378:metabolism; D019295:Computational Biology; D020022:Genetic Predisposition to Disease; D006801:Humans; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000378:metabolism; D000077288:Troglitazone
chemical_list: D000970:Antineoplastic Agents; D002839:Chromans; D045162:Thiazolidinediones; D000077288:Troglitazone